2025 was the year protein ‘jumped the shark’
Thirty years ago, when I began studying protein metabolism, I would never have guessed that 2025 would be spent explaining why more protein is not always better. Protein was once the quiet macronutrient that was always assumed sufficient. Carbs had their era, and fat had its moment in the sun. Protein arrived late, but I […]
More Americans may be classified as obese under new definition, study suggests
New criteria for obesity are putting more Americans into that category. Researchers at Mass General Brigham have proposed a major update to how obesity is defined, which would classify nearly 70% of U.S. adults as obese, according to a new study published in JAMA Network Open. The new benchmark adds waist and body fat measurements […]
This week’s new Audiobooks
Here are this week’s new releases for the category ‘Audiobooks’. ★ Our Staff Pick ★ The Viper: A Zig & Nola Novel (Escape Artist) By Brad Meltzer Publisher: HarperCollins Publication date: January 6, 2026 ISBN: 9798228697621 Share this book on Twitter | Facebook The Primal Hunter 13: A LitRPG Adventure By Zogarth (Author), Travis Baldree […]
How eggs can help you come off Wegovy: Cracking the problem of weight-regain
For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises an awkward question that more […]
Samsung’s AI companion push could fuel a pricier upgrade cycle
Samsung Electronics is wagering that your next big home improvement won’t just be bigger displays or shinier appliances. Instead, it will be a tighter web of AI features that makes it tougher to keep up with outdated hardware. Samsung introduced its “Companion to AI Living” presentation this week at CES 2026 in Las Vegas. Leadership […]
GLP-1 Drug Market Changes; Wegovy Pill Hits Shelves; Hypercortisolism Drug Rejected
(MedPage Today) — A pill formation, a stronger injectable, and more cash payment options: lots of changes are coming to the GLP-1 drug market. (NBC News) The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk…
Semaglutide improves knee replacements for patients with diabetes
For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications.
Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
A daily pill for weight loss has officially arrived in the U.S.
Can the US Launch of NVO’s Wegovy Pill Reignite Momentum in 2026?
Shares of Novo Nordisk NVO jumped 5.2% on Monday and about 4% in the pre-market hours today as investors cheered the U.S. launch of its newly approved Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular […]
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America – PR Newswire
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America PR Newswire Wegovy is now available as a pill. Here’s what you need to know CNN First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC Wegovy obesity pill now available at pharmacies : Shots […]